Literature DB >> 3939666

Role of noradrenergic function in the opiate antagonist facilitation of spatial memory.

R J Fanelli, R A Rosenberg, M Gallagher.   

Abstract

Animals previously trained to criterion on an eight-arm radial maze task received either bilateral 6-hydroxydopamine lesions of the dorsal noradrenergic bundle (DNB) or control surgery. Following a 3-week recovery period, the animals were trained on the same radial maze in two novel environments. By a within-subjects design, in one of these environments animals received posttraining systemic treatment with the opiate antagonist naloxone; in the other novel environment, they received vehicle injection. In animals that received control surgery, opiate antagonist treatment produced a reliable enhancement of performance. Although the DNB-lesion animals did not differ from the control-surgery animals under the saline treatment condition, denervation of forebrain norepinephrine (NE) was found to prevent the memory enhancing effect of posttraining naloxone administration. These results provide further support that enhanced retention obtained with opiate antagonist administration is dependent upon intact NE function.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3939666     DOI: 10.1037//0735-7044.99.4.751

Source DB:  PubMed          Journal:  Behav Neurosci        ISSN: 0735-7044            Impact factor:   1.912


  3 in total

Review 1.  Peripheral modulation of learning and memory: enkephalins as a model system.

Authors:  G Schulteis; J L Martinez
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

2.  Involvement of the amygdala in the memory-enhancing effects of clenbuterol.

Authors:  I B Introini-Collison; B Miyazaki; J L McGaugh
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

3.  Beta-adrenergic receptors in the lateral nucleus of the amygdala contribute to the acquisition but not the consolidation of auditory fear conditioning.

Authors:  David E A Bush; Ellen M Caparosa; Anna Gekker; Joseph Ledoux
Journal:  Front Behav Neurosci       Date:  2010-10-26       Impact factor: 3.558

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.